Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to -$1.6 million.

  • Cardio Diagnostics Holdings' Net Cash Flow fell 33960.62% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 36548.11%. This contributed to the annual value of $6.5 million for FY2024, which is 33090.93% up from last year.
  • Latest data reveals that Cardio Diagnostics Holdings reported Net Cash Flow of -$1.6 million as of Q3 2025, which was down 33960.62% from -$1.7 million recorded in Q2 2025.
  • Cardio Diagnostics Holdings' Net Cash Flow's 5-year high stood at $9.3 million during Q2 2022, with a 5-year trough of -$4.8 million in Q4 2022.
  • Over the past 5 years, Cardio Diagnostics Holdings' median Net Cash Flow value was -$96422.5 (recorded in 2021), while the average stood at $356278.2.
  • Data for Cardio Diagnostics Holdings' Net Cash Flow shows a peak YoY increase of 2719864.23% (in 2022) and a maximum YoY decrease of 728952.59% (in 2022) over the last 5 years.
  • Cardio Diagnostics Holdings' Net Cash Flow (Quarter) stood at $526625.0 in 2021, then tumbled by 1020.29% to -$4.8 million in 2022, then soared by 51.59% to -$2.3 million in 2023, then skyrocketed by 349.13% to $5.8 million in 2024, then tumbled by 127.57% to -$1.6 million in 2025.
  • Its Net Cash Flow was -$1.6 million in Q3 2025, compared to -$1.7 million in Q2 2025 and $1.9 million in Q1 2025.